Researchers at Vanderbilt University (MO, USA) and Washington University School of Medicine (MO, USA) have isolated a monoclonal antibody, known as ZIK-117, which has exhibited a demonstrable effect on reducing infection of the Zika virus in mouse models. The findings were published recently in Nature.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.